The latest headlines across every section, pulled from official and open-access sources.
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate is active in adults, leading analysts to predict the molecule “could re-imagine the ... therapeutic landscape” if the biotech replicates the data in children.
An annual update on the government's New Hospital Programme, a major infrastructure initiative to transform hospital design, delivery and operation in England.
Precision immunology company Scipher Medicine will absorb Chemomab Therapeutics after having identified the Israeli biotech’s liver disease drug as the ideal fit for its own expertise.
Data submission deadlines and publication dates for the COVER programme.
Insurers that sell plans in Obamacare marketplaces across 16 states and the District of Columbia have asked regulators to approve a 14% median premium increase for 2027, according to a new Peterson-KFF analysis.
Many Americans are shopping around for affordable options as the cost of health insurance soars. But some who hope to keep the same doctors and medications face a thicket of red tape and disruption after they switch plans.
Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution, which uses groundbreaking upright treatment technology.
Performing well in controlled settings is only part of the picture, the harder question is whether AI is being integrated into clinical workflows in ways that keep responsibility, authority, and accountability properly aligned. The post Healthcare and AI are in Need of Relationship Counseling appeared first on MedCity News .
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & Co.’s chronic obstructive pulmonary disease drug Ohtuvayre.
Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B appeared first on MedCity News .
Psychiatry
This randomized clinical trial assesses whether 10 sessions of once-daily intermittent theta-burst stimulation improve depressive symptoms more than sham among adults with major depressive disorder.
This cohort study evaluates the outcomes of germline pathogenic variants associated with increased breast cancer risk in the prognosis of women with primary invasive lobular carcinoma.
This randomized clinical trial assesses whether targeted intraoperative hygiene measures could reduce surgical site contamination with Cutibacterium acnes in male patients undergoing cardiac surgery.
This economic evaluation evaluates 4 low-dose computed tomographic (LDCT) screening strategies to identify the minimum risk model performance required for targeted lung cancer screening for individuals in Singapore who have never smoked.
This cross-sectional study uses data from the 2023-2024 Behavioral Risk Factor Surveillance System to examine the association between prior childhood sexual abuse and adult loneliness in the US population and whether this association varies by sex, race and ethnicity, and age group.
This cohort study examines the association of birth weight decile range with infant and child growth.
This cross-sectional study examines what percentage of mental health treatment facilities in the US offer telehealth services for children and what factors are associated with offering any telehealth services and medication management via telehealth.
Government announces 10 Year Capital Plan to modernise NHS buildings, upgrade GP surgeries and bring more care closer to patients’ homes.
Elevance filed a lawsuit last week against the Department of Health and Human Services and the Centers for Medicare & Medicaid Services, alleging that CMS unlawfully refused to recalculate Elevance’s 2026 Medicare Advantage Star Ratings on the same basis that it recently recalculated Clover Health’s ratings after a court ruling. The post Elevance Sues CMS Over Star Ratings, Seeks Same Recalculation Applied to Clover appeared first on MedCity News .
Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals values the company at about $10 billion. Crinetics’s Palsonify could become a new standard of care therapy for acromegaly and the biotech also brings other drugs in various stages of development for endocrine disorders, a new therapeutic area for Vertex. The post Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A Deal appeared first on MedCity News .
Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
CDC alert: Recall of frozen blueberries linked to E. coli outbreak; do not eat recalled product.
The Orphan Drug Designation program provides orphan status to drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons